Upacicalcet: First Approval-Reference-Cited by-同舟云学术

Upacicalcet: First Approval

Published:2021-08-14 Issue:13 Volume:81 Page:1593-1596
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Hoy Sheridan M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-021-01578-y.pdf

Reference13 articles.

1. Ketteler M, Ambuhl P. Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease. J Nephrol. 2021. https://doi.org/10.1007/s40620-021-01082-2.

2. Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011;6(4):913–21.

3. Rroji M, Spasovski G. Calcimimetics versus parathyroidectomy: what is preferable? Int Urol Nephrol. 2018;50(7):1271–5.

4. Komaba H, Ketteler M, Cunningham J, et al. Old and new drugs for the management of bone disorders in CKD. Calcif Tissue Int. 2021;108(4):486–95.

5. Kissei Pharmaceutical Co. Ltd. Announcement of Marketing Authorization Approval in Japan and co-promotion agreement of UPASITA® IV injection syringe for the treatment of secondary hyperparathyroidism in dialysis patients [media release]. 23 Jun 2021. https://www.kissei.co.jp.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current therapeutic approach of chronic kidney disease‐mineral and bone disorder;Therapeutic Apheresis and Dialysis;2024-06-19

2. Switching from etelcalcetide to upacicalcet in maintenance hemodialysis patients;Nihon Toseki Igakkai Zasshi;2024

3. Pharmacological profile of upacicalcet, a novel positive allosteric modulator of calcium-sensing receptor, in vitro and in vivo;European Journal of Pharmacology;2023-10

4. Phase 2 study of upacicalcet in Japanese haemodialysis patients with secondary hyperparathyroidism: an intraindividual dose-adjustment study;Clinical Kidney Journal;2023-09-04

5. Synthetic Approaches to the New Drugs Approved During 2021;Journal of Medicinal Chemistry;2023-08-01